Postliver Transplant Allograft Reinfection with a Lamivudine-Resistant Strain of Hepatitis B Virus: Long Term Follow-up
Lamivudine is a nucleoside analogue with efficacy in the suppression of hepatitis B viral (HBV) replication. In a previously reported study, lamivudine was administered to patients with chronic, actively replicating HBV infection who subsequently underwent liver transplantation. Patients became seru...
Main Authors: | Eric M Yoshida, Mang M Ma, Jennifer E Davis, Karl P Fischer, Norman M Kneteman, Siegfried R Erb, D Lorne Tyrrell, Vincent G Bain |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
1998-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/1998/617039 |
Similar Items
-
Postliver Transplant Immunosuppression: The Song Does Not Remain the Same
by: Eric M Yoshida
Published: (2002-01-01) -
Graft-versus-host disease: Rare complication postliver transplant
by: Nivedita Pandey, et al.
Published: (2019-01-01) -
Milan-out Criteria and Worse Intention-to-Treat Outcome Postliver Transplantation
by: Julia Herreras, MD, et al.
Published: (2019-10-01) -
A case of acute graft-versus-host disease in postliver transplantation
by: Vikas Dineshkumar Patel, et al.
Published: (2017-01-01) -
Elevated Preoperative Serum Bilirubin Improves Reperfusion Injury and Survival Postliver Transplantation
by: Vinzent Spetzler, MD, et al.
Published: (2017-08-01)